Canada Life’s Black Diamond Therapeutics BDTX Stock Holding History

Canada Life’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-879	Closed	-$7K	–	2507
2021 Q3	$7K	Hold	879	–	–	﹤0.01%	2515
2021 Q2	$11K	Hold	879	–	–	﹤0.01%	2533
2021 Q1	$21K	Hold	879	–	–	﹤0.01%	2494
2020 Q4	$28K	Hold	879	–	–	﹤0.01%	2471
2020 Q3	$27K	Hold	879	–	–	﹤0.01%	2358
2020 Q2	$37K	Buy	+879	New	+$32.4K	﹤0.01%	2323

Other funds holding BDTX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Life's BDTX Position: Q4 2021 in Review

Canada Life sold out of Black Diamond Therapeutics (BDTX) in Q4 2021, closing a stake of 879 shares — an estimated $7K sold.

Canada Life first reported a position in BDTX in Q2 2020 and held it in 6 quarters. The position peaked at $37K in Q2 2020. 95 funds tracked by Wall St. Rank hold BDTX as of Q4 2021.

Canada Life reported no remaining Black Diamond Therapeutics position as of Q4 2021 after selling out during the quarter.
Canada Life sold 879 Black Diamond Therapeutics shares in Q4 2021, an estimated $7K.
Canada Life first reported a position in Black Diamond Therapeutics in Q2 2020 and held it in 6 quarters.
Canada Life's Black Diamond Therapeutics position peaked at $37K in Q2 2020.
95 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.